Urinary carboxyterminal telopeptide of collagen I as a potential marker of bone resorption in multiple myeloma:: Comparison with pyridinolines.

被引：0
|
作者：
Houzé, P
Brouet, JC
Bouro, F
Bousquet, B
机构：
[1] Hop St Louis, Biochim Lab, F-75475 Paris, France
[2] Hop St Louis, Serv Immunohematol, F-75475 Paris, France
[3] CIS Bio Int, Gif Sur Yvette, France
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 1999年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
F062
引用
收藏
页码：S225 / S225
页数：1
相关论文
共 50 条
  • [1] Osteoclasts generate NTx the collagen telopeptide marker of bone resorption, but not free pyridinolines.
    Apone, S
    Lee, M
    Eyre, D
    JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : S396 - S396
  • [2] Urinary carboxyterminal telopeptide of collagen I as a potential marker of bone metastases chemotherapy monitoring in breast cancer
    Houzé, P
    Bellik, B
    Extra, JM
    Bouro, F
    Bousquet, B
    CLINICA CHIMICA ACTA, 1999, 281 (1-2) : 77 - 88
  • [3] Bone resorption markers after spinal cord injury: Comparison between free and total urinary pyridinolines.
    Roth, M
    Hartmann, D
    Uebelhart, D
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : S586 - S586
  • [4] Beta-carboxyterminal telopeptide of type I collagen as a serum biochemical marker of bone resorption in haemodialysis patients. A preliminary study
    Di Maggio, Arcangelo
    Godino, Francesco
    Montemurro, Nicola Ettore
    Santese, Domenico
    Coviello, Francesco
    Lodeserto, Cosimo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 139 - 140
  • [5] The determining role of a resorption marker, carboxyterminal telopeptide of collagen I, in assessing therapeutic compliance in patients treated with oral bisphosphonates
    Martinez-Laguna, D.
    Nogues, X.
    Carbonell-Abella, C.
    Castro A, Soria
    Lopez P, Orozco
    Martinez R, Poza
    Diez-Perez, A.
    Prieto-Alhambra, D.
    REVISTA DE OSTEOPOROSIS Y METABOLISMO MINERAL, 2019, 11 (01) : 19 - 24
  • [6] Carboxyterminal telopeptide of type I collagen (ICPT) - A potential serum marker in diagnosis of advanced breast cancer
    Keskikuru, R
    Jukkola, A
    Risteli, J
    Risteli, L
    Kataja, V
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S6 - S6
  • [7] Comparison of urinary markers for bone resorption in multiple myeloma
    Houzé, P
    Bellik, B
    Brouet, JC
    Bouro, F
    Bousquet, B
    CLINICA CHIMICA ACTA, 2000, 300 (1-2) : 181 - 193
  • [8] Serum carboxyterminal telopeptide of type I collagen is a progrostic marker in breast cancer patient with bone metastasis.
    Wakita, K
    Kohno, N
    Takao, S
    Konishi, M
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S127 - S127
  • [9] Procollagen I carboxyterminal propeptide (PICP) as a bone formation marker and carboxyterminal telopeptide of type I collagen (ICTP) as a bone degradation marker in children with chronic renal failure under conservative therapy
    Polak-Jonkisz, Dorota
    Zwolinska, Danuta
    Bednorz, Renata
    Owczarek, Henryk
    Szymanska, Anna
    Nahaczewska, Wieslawa
    MEDICAL SCIENCE MONITOR, 2003, 9 (01): : CR19 - CR23
  • [10] Bone resorption parameters serum carboxy-terminal telopeptide of type-I collagen (ICTP), urinary amino-terminal collagen type-I telopeptide (NTx) and deoxypyridinoline (Dpd) in MGUS and multiple myeloma.
    Jakob, C
    Niemöller, K
    Heider, U
    Zavrski, I
    Eucker, J
    Possinger, K
    Sezer, O
    BLOOD, 2001, 98 (11) : 159A - 159A
12345